Akers Biosciences Inc. Company Name:
AKER Stock Symbol:
NASDAQ Market:
Akers Biosciences Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol " MYMD " Upon Closing, the Combined Company will focus on developing and commercializing novel immunotherapy pipeline assets, including its lead molecule MYMD-1 ...
Akers Biosciences, Inc. (NASDAQ: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending health lifespan and treating immune mediated illnesses, has reached an agreement...
Chaired by Katharine Whartenby, Ph.D., members include experts in molecular medicine, aging, pathology and oncology Akers Biosciences, Inc. (Nasdaq: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage ph...